Oncology and Cancer Services Key Documents

West Midlands Cancer Alliance Policy and Guidelines for the Investigation, Diagnosis and Management of Patients with Malignancy of an Unknown Origin (MUO) and Cancer of an Unknown Primary (CUP) 

Review date - 16th July 2022

This is the most current document and should be used until a revised version is in place  

Worcester Acute Hospitals NHS local pathway for referral of all patients with a metastatic cancer of unknown origin/cancer of unknown primary

Review date - 21st April 2022 

This is the most current document and should be used until a revised version is in place

Operational escalation policy for monitoring cancer 14/31/62 day targets 

Review date - 3rd December 2022

This is the most current document and should be used until a revised version is in place

Key worker policy

Review date - 26th October 2022

This is the most current document and should be used until a revised version is in place

Policy for the Management of Cancer patients for whom Drugs their Clinicians have recommended are not available on the NHS

Review date - 6th December 2022

This is the most current document and should be used until a revised version is in place

Review date - 28th September 2022

This is the most current document and should be used until a revised version is in place

Operational guideline for cancer services

Review date - 5th October 2023

This is the most current document and should be used until a revised version is in place

Nurse led 2 week wait clinic for suspected colorectal cancer patients  

Review date - 8th July 2021 

This is the most current document and should be used until a revised version is in place  

Network Guidance - (SACT and Management Policy for Adult Patients)

Review date - 15th May 2022

This is the most current document and should be used until a revised version is in place

Guideline for the management of Immune related Adverse Reactions following Immunotherapy Treatment

Review date - 14th October 2023 

This is the most current document and should be used until a revised version is in place

Guideline for the Management of Extravasation of a systemic Anti-Cancer therapy (SACT) including Cytotoxic (Additional Local management Guidance)

Review date - 10th September 2024

This is the most current document and should be used until a revised version is in place

Guidelines for the Management of Extravasation of a systemic Anti-Cancer therapy (SACT) including Cytotoxic agents - (West Midlands EAG for SACT)

Review date - 16th December 2022

This is the most current document and should be used until a revised version is in place 

Cancer Quality Surveillance Policy 

Review date - 23rd May 2021

This is the most current document and should be used until a revised version is in place

West Midlands Cancer Alliance Guideline for the use of Antiemetics in adults receiving Anticancer Drug Therapy 

Review Date – 12th December 2022

This is the most current document and should be used until a revised version is in place

Guidance for handling the spillage of Systemic Anti-Cancer Therapy (SACT) drugs

Review date - 28th September 2022

This is the most current document and should be used until a revised version is in place

The following documents are Birmingham Children's Hospital policies and permission has been granted for these to be used- 

Cover letter for Paediatric Oncology Policies

Guideline for the Management of Tumour Lysis Syndrome

Guideline for the Administration of Chemotherapy for Malignant Disease 

Guideline for the immunisation of Children following treatment with Standard-dose Chemotherapy 

Guideline for the immunisation of Children following treatment with high-dose Chemotherapy 

Procedure for the managment of body waste and clinical samples from patients receiving Cytotoxic drugs 

CCLG and Birmingham Women's and Children's Hospital Guideline on the Management of Chemotherapy Induced Nausea and Vomiting

Guideline for the prevention, recognition and management of fever in Children and Young People with Cancer 

Procedure for the Management of spillage of cytotoxic drugs 

Policy for the use of personal protective Equipment when handling chemotherapy, spillage of chemotherapy, body waste and/or clinical samples from patients receiving chemotherapy 

Policy for the Care and Management of central venous catheters 

Policy for the care and management of ports 

Policy on the Handling of chemotherapy by staff who are pregnant or breastfeeding 

Guidelines for the Prevention and Management of Chemotherapy and Radiotherapy induced Diarrhoea